Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

David Kuntz

Hand Surgery Lebanon, PA Medical Doctor

NPI 1063413425 CMS profile 47404

912 Russell Dr, Lebanon, PA 17042

Open in the dashboard

General payments

$1,391

3 records reported · program years 2019–2024

Research payments

$160

Paid to them · 1 record reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, David Kuntz of Lebanon, PA is reported in the CMS Open Payments database as having received $1,391 across 3 general payments and $160 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 42nd percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $73 1
2019 General $1,318 2
2019 Research $160 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Kuntz
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to David Kuntz were reported at $0. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year David Kuntz Hand Surgery median Middle half National median
2019 $1,318 $383 $106–$1,905 $163
2020 $0 $172 $51–$1,268 $114
2021 $0 $263 $71–$1,591 $132
2022 $0 $336 $87–$1,938 $149
2023 $0 $233 $81–$1,114 $160
2024 $73 $258 $88–$1,203 $164
2025 $0 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. AxoGen $1,318 2 payments
  2. Novus Surgical Consultants $73 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $760 2 payments
  2. Travel and Lodging $631 1 payment
Products named General payments · program years 2019–2024
  1. AxoGuard Nerve Connector $1,318 2 payments
  2. AXOGUARD NERVE PROTECTOR $1,318 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Orthofix Medical, Inc. $160 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

136

Median for Hand Surgery: 118

Drug cost

$342

Median for Hand Surgery: $615

Branded share of claims

47.8%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 58 $180
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 65 $140
Tramadol Hcl Generic 13 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 71 billing codes

Paid by Medicare

$74,791

Of which drugs: $10,171

Medicare patients

395

Average age 73

Services billed

1,279

234 women, 161 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 74%
Diabetes 29%
Ischemic heart disease 27%
Depression 25%
Chronic kidney disease 24%
Osteoporosis 20%
COPD 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg J0702 Office 44 67 $359
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 36 148 $106

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

4 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record